Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 70S bacterial ribosome is a large ribonucleoprotein complex found in prokaryotes, consisting of a 30S small subunit and a 50S large subunit[7][9]. It is responsible for the translation of messenger RNA (mRNA) into proteins, a central process in cell biology[1][7][9]. The 30S subunit contains 16S rRNA and around 20 proteins, while the 50S subunit contains 23S and 5S rRNAs and approximately 33 proteins[7]. The ribosome features three tRNA binding sites (A, P, E) and serves as the primary target for many clinically important antibiotics, which exploit structural differences between prokaryotic (70S) and eukaryotic (80S) ribosomes to achieve selective inhibition[1][2][6][7]. Structural studies at near-atomic resolution have provided detailed insights into antibiotic binding sites and ribosomal function[1][2][3]. The 70S ribosome is considered a validated therapeutic target, especially in the context of treating bacterial infections and addressing antibiotic resistance[1][2][3].
Inhibition of peptide bond formation; Blockade of ribosome translocation or tRNA binding; Interference with decoding or initiation of mRNA translation
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 70S bacterial ribosome (70S ribosome).